Brain glutamine by MRS in a patient with urea cycle disorder and coma. 2005

Jasna Kojic, and Patricia L Robertson, and Douglas J Quint, and Donna M Martin, and Yuxi Pang, and Pia C Sundgren
Department of Pediatrics, the University of Michigan School of Medicine, Ann Arbor, MI 48109-0203, USA.

In patients who undergo metabolic decompensation from urea cycle disorders, cerebrospinal fluid glutamine level may be a better marker of cerebral dysfunction than blood ammonia or glutamine levels. However, obtaining cerebrospinal fluid by lumbar puncture carries risk in these acutely ill patients with cerebral edema. Using magnetic resonance single voxel spectroscopy as an alternative to cerebrospinal fluid analysis, elevated brain glutamine/glutamate complex levels were detected in a patient with carbamyl phosphate synthetase deficiency, who had been comatose for many days after normalization of blood ammonia and improvement in blood glutamine levels. Brain glutamine by single voxel spectroscopy decreased toward normal with neurologic recovery. We conclude that brain glutamine may be a better marker than serum ammonia for the management of urea cycle disorders, particularly in patients with prolonged mental status changes.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D001921 Brain The part of CENTRAL NERVOUS SYSTEM that is contained within the skull (CRANIUM). Arising from the NEURAL TUBE, the embryonic brain is comprised of three major parts including PROSENCEPHALON (the forebrain); MESENCEPHALON (the midbrain); and RHOMBENCEPHALON (the hindbrain). The developed brain consists of CEREBRUM; CEREBELLUM; and other structures in the BRAIN STEM. Encephalon
D005260 Female Females
D005973 Glutamine A non-essential amino acid present abundantly throughout the body and is involved in many metabolic processes. It is synthesized from GLUTAMIC ACID and AMMONIA. It is the principal carrier of NITROGEN in the body and is an important energy source for many cells. D-Glutamine,L-Glutamine,D Glutamine,L Glutamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D016896 Treatment Outcome Evaluation undertaken to assess the results or consequences of management and procedures used in combating disease in order to determine the efficacy, effectiveness, safety, and practicability of these interventions in individual cases or series. Rehabilitation Outcome,Treatment Effectiveness,Clinical Effectiveness,Clinical Efficacy,Patient-Relevant Outcome,Treatment Efficacy,Effectiveness, Clinical,Effectiveness, Treatment,Efficacy, Clinical,Efficacy, Treatment,Outcome, Patient-Relevant,Outcome, Rehabilitation,Outcome, Treatment,Outcomes, Patient-Relevant,Patient Relevant Outcome,Patient-Relevant Outcomes
D018698 Glutamic Acid A non-essential amino acid naturally occurring in the L-form. Glutamic acid is the most common excitatory neurotransmitter in the CENTRAL NERVOUS SYSTEM. Aluminum L-Glutamate,Glutamate,Potassium Glutamate,D-Glutamate,Glutamic Acid, (D)-Isomer,L-Glutamate,L-Glutamic Acid,Aluminum L Glutamate,D Glutamate,Glutamate, Potassium,L Glutamate,L Glutamic Acid,L-Glutamate, Aluminum
D020127 Recovery of Function A partial or complete return to the normal or proper physiologic activity of an organ or part following disease or trauma. Function Recoveries,Function Recovery
D020165 Carbamoyl-Phosphate Synthase I Deficiency Disease A urea cycle disorder manifesting in infancy as lethargy, emesis, seizures, alterations of muscle tone, abnormal eye movements, and an elevation of serum ammonia. The disorder is caused by a reduction in the activity of hepatic mitochondrial CARBAMOYL-PHOSPHATE SYNTHASE (AMMONIA). (Menkes, Textbook of Child Neurology, 5th ed, pp50-1) CPS 1 Deficiency,Carbamoyl-Phosphate Synthase I Deficiency Disease (Ornithine Carbamoyl Phosphate Deficiency),Carbamyl-Phosphate Synthetase I Deficiency Disease,Hyperammonemia Due to Carbamoyl Phosphate Synthetase 1 Deficiency,CPS I Deficiency,Carbamoyl Phosphate Synthase (Ammonia) Deficiency Disease,Carbamoyl Phosphate Synthase 1 Deficiency,Carbamoyl Phosphate Synthetase I Deficiency,Carbamoyl Phosphate Synthetase I Deficiency, Hyperammonemia Due To,Carbamoyl-Phosphate Synthase 1 Deficiency Disease,Carbamoyl-Phosphate Synthase 1 Deficiency Disease (Ornithine Carbamoyl Phosphate Deficiency),Carbamoyl-Phosphate Synthetase I Deficiency Disease,Carbamoylphosphate Synthetase 1 Deficiency Disease -,Carbamoylphosphate Synthetase I Deficiency Disease,Carbamyl Phosphate Synthetase (CPS) Deficiency,Carbamyl Phosphate Synthetase Deficiency Disease,Carbamyl-Phosphate Synthetase 1 Deficiency Disease,CPS 1 Deficiencies,CPS I Deficiencies,Carbamoyl Phosphate Synthase 1 Deficiency Disease,Carbamoyl Phosphate Synthase 1 Deficiency Disease (Ornithine Carbamoyl Phosphate Deficiency),Carbamoyl Phosphate Synthetase I Deficiency Disease,Carbamoylphosphate Synthetase 1 Deficiency Disease,Carbamyl Phosphate Synthetase 1 Deficiency Disease,Carbamyl Phosphate Synthetase I Deficiency Disease

Related Publications

Jasna Kojic, and Patricia L Robertson, and Douglas J Quint, and Donna M Martin, and Yuxi Pang, and Pia C Sundgren
May 2017, Molecular genetics and metabolism,
Jasna Kojic, and Patricia L Robertson, and Douglas J Quint, and Donna M Martin, and Yuxi Pang, and Pia C Sundgren
March 2013, Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine,
Jasna Kojic, and Patricia L Robertson, and Douglas J Quint, and Donna M Martin, and Yuxi Pang, and Pia C Sundgren
July 2015, Genetics in medicine : official journal of the American College of Medical Genetics,
Jasna Kojic, and Patricia L Robertson, and Douglas J Quint, and Donna M Martin, and Yuxi Pang, and Pia C Sundgren
September 2016, The American journal of emergency medicine,
Jasna Kojic, and Patricia L Robertson, and Douglas J Quint, and Donna M Martin, and Yuxi Pang, and Pia C Sundgren
July 2016, The American journal of emergency medicine,
Jasna Kojic, and Patricia L Robertson, and Douglas J Quint, and Donna M Martin, and Yuxi Pang, and Pia C Sundgren
February 2008, Journal of clinical gastroenterology,
Jasna Kojic, and Patricia L Robertson, and Douglas J Quint, and Donna M Martin, and Yuxi Pang, and Pia C Sundgren
May 2015, Genetics in medicine : official journal of the American College of Medical Genetics,
Jasna Kojic, and Patricia L Robertson, and Douglas J Quint, and Donna M Martin, and Yuxi Pang, and Pia C Sundgren
January 2016, Molecular genetics and metabolism,
Jasna Kojic, and Patricia L Robertson, and Douglas J Quint, and Donna M Martin, and Yuxi Pang, and Pia C Sundgren
April 2021, Journal of clinical neurology (Seoul, Korea),
Jasna Kojic, and Patricia L Robertson, and Douglas J Quint, and Donna M Martin, and Yuxi Pang, and Pia C Sundgren
December 2002, Annales francaises d'anesthesie et de reanimation,
Copied contents to your clipboard!